Publish with Us

Cell Engineering Connect

Aims and Scope

The Cell Engineering Connect is a peer-reviewed, open-access journal, that aims to publish cutting-edge research and innovative approaches in the rapidly evolving field of cell engineering. This journal serves as a platform for advancing knowledge in the manipulation, design, and application of cells for therapeutic and diagnostic purposes.

The scope of the journal includes, but is not limited to, the following key areas:

  • Genetic Engineering and Synthetic Biology: Investigating techniques such as genome editing, CRISPR technology, and synthetic biology for disease modeling, gene therapy, metabolic engineering, and the development of novel cell-based systems.
  • Stem Cell Engineering: Covering advancements in stem cell research, including the development of organoids, disease models, and organs-on-a-chip for drug discovery, personalized medicine, and regenerative therapies.
  • Cell-based Therapy: Exploring cell-based therapeutic approaches like CAR-T cell therapy, immune cell modulation, and the use of engineered cells for the production of therapeutic agents.
  • Tissue Engineering and Regenerative Medicine: Focusing on the creation and regeneration of tissues and organs through bioengineering methods, including scaffold design, bioprinting, and stem cell integration.
  • Immunoengineering: Examining the interface between immune cells and engineered systems, including innovations in cancer immunotherapy, vaccine development, and autoimmune disease treatment.
  • Neuroengineering: Investigating the engineering of neural cells and tissues to develop treatments for neurodegenerative diseases, brain injury, and other neurological conditions.
  • Cellular Mechanobiology: Designing and manipulating the physical, chemical, and biological conditions surrounding cells to control their behavior, growth, and function for applications in tissue engineering, regenerative medicine, and disease modeling.
  • Biomanufacturing: Producing engineered cells for practical applications and/or producing therapeutic agents (DNA/RNA, proteins, exosomes, and so on) by using engineered cells.
  • AI in Cell Engineering: Using AI in cell engineering to optimize gene editing, predict cellular behaviors, analyze large-scale biological data, automate cell culture processes, and enhance the precision of techniques like CRISPR by identifying target genes more efficiently.